...Pharmaceutical Co. Ltd., Gruppo Angelini, Incyte Corp., Medison Pharma Ltd., Otsuka Pharmaceutical Co. Ltd. and Specialised Therapeutics Australia Pty. Ltd....

...treatment-naïve patients PDUFA date September PharmaMar S.A. (Madrid:PHM) / Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) / Specialised Therapeutics Australia Pty. Ltd....

...testing additional stabilizers of FAM9B G-quadruplex DNA in humanized models of ATR-X. Medac GmbH and Specialised Therapeutics Australia Pty. Ltd....

...Pharmaceutical Co. Ltd., Gruppo Angelini, Incyte Corp., Medison Pharma Ltd., Otsuka Pharmaceutical Co. Ltd. and Specialised Therapeutics Australia Pty. Ltd....

...conjugate in additional models of TNBC. Celgene Corp., BeiGene Ltd., Biocon Ltd., Green Cross Corp., Specialised Therapeutics Australia Pty. Ltd....
...Ltd. market Abraxane, an albumin-stabilized nanoparticle formulation of paclitaxel, to treat breast cancer. Celgene, BeiGene, Specialised Therapeutics Australia...

...its active state. Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) has exclusive, Japanese rights to Zepsyre, while Specialised Therapeutics Australia Pty. Ltd....
...see BioCentury, Dec. 29, 2016 & June 8, 2017 ). PharmaMar S.A. (Madrid:PHM), Madrid, Spain Specialised Therapeutics Australia Pty. Ltd....
...overall response rate (ORR) Status: Phase III data Milestone: NA Jaime De Leon lurbinectedin PM01183 PM1183 Zepsyre Chugai Pharmaceutical Co. Ltd. PharmaMar S.A. Specialised Therapeutics Australia Pty. Ltd. RNA...

...Additional Ph III data 1H18 PharmaMar S.A. (Madrid:PHM) / Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) / Specialised Therapeutics Australia Pty. Ltd....

...overall survival (OS). Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) has exclusive, Japanese rights to Zepsyre, while Specialised Therapeutics Australia Pty. Ltd....
...targeting RNA polymerase II (Pol II) in its active state. PharmaMar S.A. (Madrid:PHM), Madrid, Spain Specialised Therapeutics Australia Pty. Ltd....
...1-year overall survival (OS) Status: Phase II data Milestone: NA Jaime De Leon lurbinectedin PM01183 PM1183 Zepsyre Chugai Pharmaceutical Co. Ltd. PharmaMar S.A. Specialised Therapeutics Australia Pty. Ltd. RNA...

...acne vulgaris Submit NDA 4Q17 PharmaMar S.A. (Madrid:PHM) / Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) / Specialised Therapeutics Australia Pty. Ltd....

...panel; PDUFA date 7/11/17; September PharmaMar S.A. (Madrid:PHM) / Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) / Specialised Therapeutics Australia Pty. Ltd....